Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional Labeling and Advertisements
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 12, 2023
December 11, 2023
bb6d5d7c-0aa7-47cd-9c04-8a080c2201b7
Related Documents
Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final
Guidance DocumentDecember 12, 2017Center for Drug Evaluation and Research
Formal Dispute Resolution: Sponsor Appeals Above the Division Level Guidance for Industry and Review Staff
Guidance DocumentMay 30, 2019Center for Drug Evaluation and Research
Special Protocol Assessment Guidance for Industry
Guidance DocumentApril 16, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox